April 16, 2018 — Medtronic plc announced U.S. Food and Drug Administration (FDA) approval to begin an investigational ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
April 16, 2018
April 5, 2018 — YMCA of the USA (Y-USA) and the American Heart Association (AHA) are combining efforts to help more ...
April 05, 2018
March 28, 2018 — Population health enablement company Higi announced their commitment to implement the 2017 American ...
March 28, 2018
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American College ...
March 27, 2018
March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the ...
March 20, 2018
March 20, 2018 — African-American men who received medical intervention aimed at controlling their high blood pressure w ...
March 20, 2018
February 16, 2018 — California’s Petaluma Health Center (PHC) was recently awarded a 2017 Healthcare Information and ...
February 16, 2018
December 6, 2017 — Women who develop high blood pressure during pregnancy are more likely to experience heart problems ...
December 06, 2017
November 16, 2017 — Findings from a landmark study funded by the National Institutes of Health (NIH) support a key ...
November 16, 2017
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...
September 14, 2017
September 6, 2017 — A new National Institutes of Health-funded hypertension trial will examine the possibility of using ...
September 06, 2017
August 31, 2017 — Medtronic plc announced its intent to move forward with a new renal denervation pivotal trial ...
August 31, 2017
August 30, 2017 — Vascular Dynamics Inc. announced interim results of the company’s first-in-human trial of its MobiusHD ...
August 30, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc. (VDI) ...
August 15, 2017
July 5, 2017 — Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of ...
July 05, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now